Regulatory T cells in Arthritis

Area of Science:

• Immunology
• Autoimmune Diseases
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a prevalent autoimmune condition causing joint inflammation and bone destruction.
• Regulatory T (Treg) cells play a critical role in preventing autoimmune diseases, including arthritis, as evidenced by studies in mice and therapeutic responses in humans.
• The plasticity of Foxp3(+) T cells, with some converting to pathogenic Th17 cells, highlights the need to identify stable, suppressive Treg subpopulations.

Purpose of the Study:

• To review the critical role of Treg cells in the pathogenesis and treatment of rheumatoid arthritis.
• To discuss the heterogeneity of Foxp3(+) T cells and the importance of identifying stable, suppressive Treg subpopulations.
• To explore emerging therapeutic strategies involving antigen-specific Treg cell generation and epigenetic modification for RA.

Main Methods:

• Review of existing human and murine studies on Treg cells in arthritis.
• Analysis of therapeutic interventions targeting Treg cells in RA models and clinical settings.
• Examination of molecular and cellular mechanisms underlying Treg cell function and plasticity.

Main Results:

• Depletion of Treg cells in mice induces autoimmune diseases, while their replenishment alleviates arthritis.
• Therapeutic strategies like CTLA4-Ig, anti-IL-6R, and anti-TNF-α treatments show effectiveness, partly through modulating Treg cell numbers and function.
• Identification of CTLA-4 as an RA-associated gene further supports the role of Treg cells in RA pathogenesis.

Conclusions:

• Treg cells are a viable therapeutic target for rheumatoid arthritis.
• Understanding Treg cell heterogeneity and plasticity is key to developing effective treatments.
• Future strategies focusing on antigen-specific Treg induction and epigenetic stabilization hold promise for novel RA therapies.